Colchicine intoxication: Clinical pharmacology, risk factors, features, and management

Chaim Putterman, Eldad Ben-Chetrit, Yoseph Caraco, Micha Levy

Research output: Contribution to journalArticlepeer-review

128 Scopus citations


The use of colchicine for acute gouty arthritis dates to ancient times. In recent years, colchicine also has been used successfully for various other rheumatic and nonrheumatic conditions. Colchicine is a safe drug when used according to established therapeutic guidelines. However, toxicity can be considerable if ingested intentionally or if the recommended doses are exceeded. Colchicine intoxication is characterized by multiorgan involvement and by the poor prognosis associated with administration of large amounts of the drug. Therapy is basically supportive and symptomatic because of the rapid distribution and binding of colchicine to the affected tissues. Use of anticolchicine antibodies is a novel approach that has shown promise in experimental models. Important research questions pertain to the effect of liver and kidney disease on colchicine metabolism, use of colchicine levels in the diagnosis of intoxication and for prognostication, and application of immunotoxicotherapy for colchicine poisoning in humans.

Original languageEnglish (US)
Pages (from-to)143-155
Number of pages13
JournalSeminars in Arthritis and Rheumatism
Issue number3
StatePublished - Dec 1991
Externally publishedYes


  • Colchicine
  • colchicine intoxication
  • familial Mediterranean fever
  • gout

ASJC Scopus subject areas

  • Rheumatology
  • Anesthesiology and Pain Medicine


Dive into the research topics of 'Colchicine intoxication: Clinical pharmacology, risk factors, features, and management'. Together they form a unique fingerprint.

Cite this